Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
暂无分享,去创建一个
E. Rubin | E. Gong | J. Verstuyft | A. Nichols | J. Schultz
[1] J. Qiao,et al. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[2] E. Rubin,et al. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. , 1992, The Journal of biological chemistry.
[3] J. Fruchart,et al. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. , 1992, Clinical chemistry.
[4] P. Wilson,et al. The MspI restriction fragment length polymorphism 3' to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease. , 1992, Atherosclerosis.
[5] G. Luc,et al. High-density lipoprotein particles in octogenarians. , 1991, Metabolism: clinical and experimental.
[6] W. J. Johnson,et al. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. , 1991, Journal of lipid research.
[7] M. Taskinen,et al. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). , 1991, Metabolism: clinical and experimental.
[8] J. Lough,et al. Pathology of atherosclerosis in cholesterol-fed, susceptible mice. , 1991, Atherosclerosis.
[9] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[10] B. G. Brown,et al. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. , 1991, Journal of lipid research.
[11] R. Krauss,et al. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Auget,et al. Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery. , 1990, Clinical chemistry.
[13] A. Lusis,et al. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. , 1990, The Journal of biological chemistry.
[14] B. Paigen,et al. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. , 1990, Arteriosclerosis.
[15] A. Lusis,et al. Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. , 1990, Journal of lipid research.
[16] J. Fruchart,et al. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III. , 1989, Atherosclerosis.
[17] C. Fielding,et al. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.
[18] J. Fruchart,et al. Apolipoprotein A-I containing lipoproteins in coronary artery disease. , 1987, Atherosclerosis.
[19] J. Fruchart,et al. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.
[20] D. Crook,et al. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit , 1985, Nature.
[21] J. Albers,et al. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. , 1984, The Journal of biological chemistry.
[22] J. Scott,et al. Isolation and characterisation of a cDNA encoding the precursor for human apolipoprotein AII. , 1984, Biochemical and biophysical research communications.
[23] W. H. Heaton,et al. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. , 1982, Arteriosclerosis.
[24] F. Grillo,et al. Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. , 1981, Clinical chemistry.
[25] H. Brewer,et al. Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[27] G. R. Bartlett. Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.